Early Stage Venture Sonoma BioTherapeutics Raises Series A of $30000000

About Sonoma BioTherapeutics

Sonoma BioTherapeutics seattle-based company leading the development of adoptive Treg therapies cell for autoimmune.

Website: Learn more on Sonoma BioTherapeutics’s website

Crunchbase: Follow on Crunchbase

Series A – Sonoma BioTherapeutics

Amount Raised30000000 USD
Announced Date2020-09-30
Equity Only FundingYes
Organization LocationSouth San Francisco, California, United States, North America
Funding StatusEarly Stage Venture
Number of Funding Rounds2
Lead Investors
Number of Investors8
Number of Partner Investors2

Written by Startup News

Early Stage Venture Shiok Meats Raises Series A of $12600000

Early Stage Venture HealthMetrics Raises Series A of $5000000